Panagiotopoulos Panos, Maniadakis Nikos, Papatheodoridis George, Pektasidis Dimitris
Medical School, National and Kapodistrian University of Athens (UOA), Athens, Greece.
National School of Public Health (NSPH), Athens, Greece.
Pharmacoecon Open. 2020 Mar;4(1):61-69. doi: 10.1007/s41669-019-0146-z.
The main aims of this study were to evaluate the Greek version of the diagnosis-related group reimbursement system (KEN-DRG) and to compare the KEN-DRG prices with the average actual cost of each group of study cases. Along with other aspects, the differences between the KEN-DRG average length of stay (ALOS) and the actual ALOS was evaluated in selected cases.
In the first part of this study, the top-down costing approach was selected in order to break down the total operating costs of the hospital, by hospital department. The aim of this stage was identification of the total operating costs and the average cost per patient day for each Internal Medicine Department of the 'Hippokration' General Hospital of Athens during the period 2014-2015. The final cost drivers were identified using the concept of cluster-related incidents in the hospital. In a subsequent stage, the 13 most frequent cancer KEN-DRG prices charged by Internal Medicine Departments were selected as a sample for further data analysis.
With regard to the costing of the oncological KEN-DRG, the present study illustrates that a majority of the current reimbursement rates for oncological KEN-DRG codes are under-reimbursed, taking into account the actual costs of hospitalization for each group of cases. The results also reveal that the ALOS of the KEN-DRG does not reflect the actual ALOS in the sample of cases examined. In addition, under the scope of this study, two proposed models for the KEN-DRG price recalculation were developed, based on the average estimated cost of hospitalization for the sample incidents, which could improve the existing reimbursement system for Greek hospitals in the medium term.
The KEN-DRG payment system that was implemented in Greece for the first time in 2012 needs redesigning in terms of the true cost of hospital services and the actual cost of each patient's treatment. With regard to the existing KEN-DRG reimbursement system, the current study suggested the use of a DRG price calculation model that consists of a relative weight factor and a base price, based on a real cost calculation process on an annual basis. Moreover, it should be stressed that the present study, as well as other related studies, make it possible to know the actual cost of hospitalization, and can contribute to the creation of a cost database over time at the level of hospitals or specific clinical departments.
本研究的主要目的是评估希腊版诊断相关分组付费系统(KEN-DRG),并将KEN-DRG价格与每组研究病例的平均实际成本进行比较。除其他方面外,还对选定病例中KEN-DRG的平均住院日(ALOS)与实际ALOS之间的差异进行了评估。
在本研究的第一部分,选择自上而下的成本核算方法,按医院科室分解医院的总运营成本。此阶段的目的是确定雅典“希波克拉底”综合医院各内科在2014 - 2015年期间的总运营成本及每位患者每天的平均成本。利用医院中与群组相关事件的概念确定最终成本驱动因素。在随后阶段,选择内科收取的13种最常见癌症KEN-DRG价格作为样本进行进一步数据分析。
关于肿瘤学KEN-DRG的成本核算,本研究表明,考虑到每组病例的实际住院成本,当前大多数肿瘤学KEN-DRG编码的报销率报销不足。结果还显示,KEN-DRG的ALOS未反映所检查病例样本中的实际ALOS。此外,在本研究范围内,基于样本事件的平均估计住院成本,开发了两种KEN-DRG价格重新计算的提议模型,这可在中期改善希腊医院现有的报销系统。
2012年首次在希腊实施的KEN-DRG支付系统需要根据医院服务的真实成本和每位患者治疗的实际成本进行重新设计。关于现有的KEN-DRG报销系统,本研究建议使用一种由相对权重因子和基准价格组成的DRG价格计算模型,该模型基于每年的实际成本计算过程。此外,应强调的是,本研究以及其他相关研究有助于了解住院的实际成本,并随着时间的推移在医院或特定临床科室层面建立成本数据库。